Global Pharmaceutical Development Preclinical CRO Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 106
Published Date: 02 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Pharmaceutical Development Preclinical CRO market size was valued at USD 11870 million in 2023 and is forecast to a readjusted size of USD 19910 million by 2030 with a CAGR of 7.7% during review period.
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care. Pharmaceutical companies invest lots of money to research and produce drugs/medicines for patients. Patients and healthcare providers (doctors, nurses, hospitals, nursing homes, clinics, etc.) are all dependent on these companies for the treatment of diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pharmaceutical Development Preclinical CRO industry chain, the market status of Small and Medium Pharmaceutical Company (Bioanalysis and DMPK Studies, Toxicology Testing), Large Pharmaceutical Company (Bioanalysis and DMPK Studies, Toxicology Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmaceutical Development Preclinical CRO.
Regionally, the report analyzes the Pharmaceutical Development Preclinical CRO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmaceutical Development Preclinical CRO market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmaceutical Development Preclinical CRO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmaceutical Development Preclinical CRO industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Bioanalysis and DMPK Studies, Toxicology Testing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmaceutical Development Preclinical CRO market.
Regional Analysis: The report involves examining the Pharmaceutical Development Preclinical CRO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmaceutical Development Preclinical CRO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmaceutical Development Preclinical CRO:
Company Analysis: Report covers individual Pharmaceutical Development Preclinical CRO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmaceutical Development Preclinical CRO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Small and Medium Pharmaceutical Company, Large Pharmaceutical Company).
Technology Analysis: Report covers specific technologies relevant to Pharmaceutical Development Preclinical CRO. It assesses the current state, advancements, and potential future developments in Pharmaceutical Development Preclinical CRO areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmaceutical Development Preclinical CRO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pharmaceutical Development Preclinical CRO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Market segment by Application
Small and Medium Pharmaceutical Company
Large Pharmaceutical Company
Market segment by players, this report covers
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Development Preclinical CRO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Development Preclinical CRO, with revenue, gross margin and global market share of Pharmaceutical Development Preclinical CRO from 2019 to 2024.
Chapter 3, the Pharmaceutical Development Preclinical CRO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharmaceutical Development Preclinical CRO market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Development Preclinical CRO.
Chapter 13, to describe Pharmaceutical Development Preclinical CRO research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Development Preclinical CRO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical Development Preclinical CRO by Type
1.3.1 Overview: Global Pharmaceutical Development Preclinical CRO Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Type in 2023
1.3.3 Bioanalysis and DMPK Studies
1.3.4 Toxicology Testing
1.3.5 Safety Pharmacology
1.3.6 Others
1.4 Global Pharmaceutical Development Preclinical CRO Market by Application
1.4.1 Overview: Global Pharmaceutical Development Preclinical CRO Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Small and Medium Pharmaceutical Company
1.4.3 Large Pharmaceutical Company
1.5 Global Pharmaceutical Development Preclinical CRO Market Size & Forecast
1.6 Global Pharmaceutical Development Preclinical CRO Market Size and Forecast by Region
1.6.1 Global Pharmaceutical Development Preclinical CRO Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Pharmaceutical Development Preclinical CRO Market Size by Region, (2019-2030)
1.6.3 North America Pharmaceutical Development Preclinical CRO Market Size and Prospect (2019-2030)
1.6.4 Europe Pharmaceutical Development Preclinical CRO Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size and Prospect (2019-2030)
1.6.6 South America Pharmaceutical Development Preclinical CRO Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Pharmaceutical Development Preclinical CRO Market Size and Prospect (2019-2030)
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River Pharmaceutical Development Preclinical CRO Product and Solutions
2.1.4 Charles River Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Charles River Recent Developments and Future Plans
2.2 Wuxi AppTec
2.2.1 Wuxi AppTec Details
2.2.2 Wuxi AppTec Major Business
2.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Product and Solutions
2.2.4 Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Wuxi AppTec Recent Developments and Future Plans
2.3 Labcorp
2.3.1 Labcorp Details
2.3.2 Labcorp Major Business
2.3.3 Labcorp Pharmaceutical Development Preclinical CRO Product and Solutions
2.3.4 Labcorp Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Labcorp Recent Developments and Future Plans
2.4 Eurofins Scientific
2.4.1 Eurofins Scientific Details
2.4.2 Eurofins Scientific Major Business
2.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Product and Solutions
2.4.4 Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eurofins Scientific Recent Developments and Future Plans
2.5 PPD, Inc.
2.5.1 PPD, Inc. Details
2.5.2 PPD, Inc. Major Business
2.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Product and Solutions
2.5.4 PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 PPD, Inc. Recent Developments and Future Plans
2.6 ICON Plc.
2.6.1 ICON Plc. Details
2.6.2 ICON Plc. Major Business
2.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Product and Solutions
2.6.4 ICON Plc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ICON Plc. Recent Developments and Future Plans
2.7 Pharmaron
2.7.1 Pharmaron Details
2.7.2 Pharmaron Major Business
2.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Product and Solutions
2.7.4 Pharmaron Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pharmaron Recent Developments and Future Plans
2.8 Inotiv
2.8.1 Inotiv Details
2.8.2 Inotiv Major Business
2.8.3 Inotiv Pharmaceutical Development Preclinical CRO Product and Solutions
2.8.4 Inotiv Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Inotiv Recent Developments and Future Plans
2.9 ChemPartner
2.9.1 ChemPartner Details
2.9.2 ChemPartner Major Business
2.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Product and Solutions
2.9.4 ChemPartner Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ChemPartner Recent Developments and Future Plans
2.10 JOINN Lab
2.10.1 JOINN Lab Details
2.10.2 JOINN Lab Major Business
2.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Product and Solutions
2.10.4 JOINN Lab Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 JOINN Lab Recent Developments and Future Plans
2.11 EVOTEC
2.11.1 EVOTEC Details
2.11.2 EVOTEC Major Business
2.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Product and Solutions
2.11.4 EVOTEC Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 EVOTEC Recent Developments and Future Plans
2.12 Medicilon
2.12.1 Medicilon Details
2.12.2 Medicilon Major Business
2.12.3 Medicilon Pharmaceutical Development Preclinical CRO Product and Solutions
2.12.4 Medicilon Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Medicilon Recent Developments and Future Plans
2.13 Crown Bioscience
2.13.1 Crown Bioscience Details
2.13.2 Crown Bioscience Major Business
2.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Product and Solutions
2.13.4 Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Crown Bioscience Recent Developments and Future Plans
2.14 Champion Oncology
2.14.1 Champion Oncology Details
2.14.2 Champion Oncology Major Business
2.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Product and Solutions
2.14.4 Champion Oncology Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Champion Oncology Recent Developments and Future Plans
3.1 Global Pharmaceutical Development Preclinical CRO Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Pharmaceutical Development Preclinical CRO by Company Revenue
3.2.2 Top 3 Pharmaceutical Development Preclinical CRO Players Market Share in 2023
3.2.3 Top 6 Pharmaceutical Development Preclinical CRO Players Market Share in 2023
3.3 Pharmaceutical Development Preclinical CRO Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical Development Preclinical CRO Market: Region Footprint
3.3.2 Pharmaceutical Development Preclinical CRO Market: Company Product Type Footprint
3.3.3 Pharmaceutical Development Preclinical CRO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Pharmaceutical Development Preclinical CRO Consumption Value and Market Share by Type (2019-2024)
4.2 Global Pharmaceutical Development Preclinical CRO Market Forecast by Type (2025-2030)
5.1 Global Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Application (2019-2024)
5.2 Global Pharmaceutical Development Preclinical CRO Market Forecast by Application (2025-2030)
6.1 North America Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2030)
6.2 North America Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2030)
6.3 North America Pharmaceutical Development Preclinical CRO Market Size by Country
6.3.1 North America Pharmaceutical Development Preclinical CRO Consumption Value by Country (2019-2030)
6.3.2 United States Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
6.3.3 Canada Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
6.3.4 Mexico Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
7.1 Europe Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2030)
7.2 Europe Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2030)
7.3 Europe Pharmaceutical Development Preclinical CRO Market Size by Country
7.3.1 Europe Pharmaceutical Development Preclinical CRO Consumption Value by Country (2019-2030)
7.3.2 Germany Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
7.3.3 France Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
7.3.5 Russia Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
7.3.6 Italy Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Region (2019-2030)
8.3.2 China Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
8.3.3 Japan Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
8.3.4 South Korea Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
8.3.5 India Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
8.3.7 Australia Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
9.1 South America Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2030)
9.2 South America Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2030)
9.3 South America Pharmaceutical Development Preclinical CRO Market Size by Country
9.3.1 South America Pharmaceutical Development Preclinical CRO Consumption Value by Country (2019-2030)
9.3.2 Brazil Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
9.3.3 Argentina Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Country (2019-2030)
10.3.2 Turkey Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
10.3.4 UAE Pharmaceutical Development Preclinical CRO Market Size and Forecast (2019-2030)
11.1 Pharmaceutical Development Preclinical CRO Market Drivers
11.2 Pharmaceutical Development Preclinical CRO Market Restraints
11.3 Pharmaceutical Development Preclinical CRO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Pharmaceutical Development Preclinical CRO Industry Chain
12.2 Pharmaceutical Development Preclinical CRO Upstream Analysis
12.3 Pharmaceutical Development Preclinical CRO Midstream Analysis
12.4 Pharmaceutical Development Preclinical CRO Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pharmaceutical Development Preclinical CRO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pharmaceutical Development Preclinical CRO Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Pharmaceutical Development Preclinical CRO Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Pharmaceutical Development Preclinical CRO Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Charles River Company Information, Head Office, and Major Competitors
Table 6. Charles River Major Business
Table 7. Charles River Pharmaceutical Development Preclinical CRO Product and Solutions
Table 8. Charles River Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Charles River Recent Developments and Future Plans
Table 10. Wuxi AppTec Company Information, Head Office, and Major Competitors
Table 11. Wuxi AppTec Major Business
Table 12. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product and Solutions
Table 13. Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Wuxi AppTec Recent Developments and Future Plans
Table 15. Labcorp Company Information, Head Office, and Major Competitors
Table 16. Labcorp Major Business
Table 17. Labcorp Pharmaceutical Development Preclinical CRO Product and Solutions
Table 18. Labcorp Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Labcorp Recent Developments and Future Plans
Table 20. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 21. Eurofins Scientific Major Business
Table 22. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product and Solutions
Table 23. Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Eurofins Scientific Recent Developments and Future Plans
Table 25. PPD, Inc. Company Information, Head Office, and Major Competitors
Table 26. PPD, Inc. Major Business
Table 27. PPD, Inc. Pharmaceutical Development Preclinical CRO Product and Solutions
Table 28. PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. PPD, Inc. Recent Developments and Future Plans
Table 30. ICON Plc. Company Information, Head Office, and Major Competitors
Table 31. ICON Plc. Major Business
Table 32. ICON Plc. Pharmaceutical Development Preclinical CRO Product and Solutions
Table 33. ICON Plc. Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. ICON Plc. Recent Developments and Future Plans
Table 35. Pharmaron Company Information, Head Office, and Major Competitors
Table 36. Pharmaron Major Business
Table 37. Pharmaron Pharmaceutical Development Preclinical CRO Product and Solutions
Table 38. Pharmaron Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Pharmaron Recent Developments and Future Plans
Table 40. Inotiv Company Information, Head Office, and Major Competitors
Table 41. Inotiv Major Business
Table 42. Inotiv Pharmaceutical Development Preclinical CRO Product and Solutions
Table 43. Inotiv Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Inotiv Recent Developments and Future Plans
Table 45. ChemPartner Company Information, Head Office, and Major Competitors
Table 46. ChemPartner Major Business
Table 47. ChemPartner Pharmaceutical Development Preclinical CRO Product and Solutions
Table 48. ChemPartner Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. ChemPartner Recent Developments and Future Plans
Table 50. JOINN Lab Company Information, Head Office, and Major Competitors
Table 51. JOINN Lab Major Business
Table 52. JOINN Lab Pharmaceutical Development Preclinical CRO Product and Solutions
Table 53. JOINN Lab Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. JOINN Lab Recent Developments and Future Plans
Table 55. EVOTEC Company Information, Head Office, and Major Competitors
Table 56. EVOTEC Major Business
Table 57. EVOTEC Pharmaceutical Development Preclinical CRO Product and Solutions
Table 58. EVOTEC Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. EVOTEC Recent Developments and Future Plans
Table 60. Medicilon Company Information, Head Office, and Major Competitors
Table 61. Medicilon Major Business
Table 62. Medicilon Pharmaceutical Development Preclinical CRO Product and Solutions
Table 63. Medicilon Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Medicilon Recent Developments and Future Plans
Table 65. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 66. Crown Bioscience Major Business
Table 67. Crown Bioscience Pharmaceutical Development Preclinical CRO Product and Solutions
Table 68. Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Crown Bioscience Recent Developments and Future Plans
Table 70. Champion Oncology Company Information, Head Office, and Major Competitors
Table 71. Champion Oncology Major Business
Table 72. Champion Oncology Pharmaceutical Development Preclinical CRO Product and Solutions
Table 73. Champion Oncology Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Champion Oncology Recent Developments and Future Plans
Table 75. Global Pharmaceutical Development Preclinical CRO Revenue (USD Million) by Players (2019-2024)
Table 76. Global Pharmaceutical Development Preclinical CRO Revenue Share by Players (2019-2024)
Table 77. Breakdown of Pharmaceutical Development Preclinical CRO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Pharmaceutical Development Preclinical CRO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Pharmaceutical Development Preclinical CRO Players
Table 80. Pharmaceutical Development Preclinical CRO Market: Company Product Type Footprint
Table 81. Pharmaceutical Development Preclinical CRO Market: Company Product Application Footprint
Table 82. Pharmaceutical Development Preclinical CRO New Market Entrants and Barriers to Market Entry
Table 83. Pharmaceutical Development Preclinical CRO Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Pharmaceutical Development Preclinical CRO Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Pharmaceutical Development Preclinical CRO Consumption Value Share by Type (2019-2024)
Table 86. Global Pharmaceutical Development Preclinical CRO Consumption Value Forecast by Type (2025-2030)
Table 87. Global Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2024)
Table 88. Global Pharmaceutical Development Preclinical CRO Consumption Value Forecast by Application (2025-2030)
Table 89. North America Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Pharmaceutical Development Preclinical CRO Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Pharmaceutical Development Preclinical CRO Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Pharmaceutical Development Preclinical CRO Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Pharmaceutical Development Preclinical CRO Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Pharmaceutical Development Preclinical CRO Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Pharmaceutical Development Preclinical CRO Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Pharmaceutical Development Preclinical CRO Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Pharmaceutical Development Preclinical CRO Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Pharmaceutical Development Preclinical CRO Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Pharmaceutical Development Preclinical CRO Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Pharmaceutical Development Preclinical CRO Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Pharmaceutical Development Preclinical CRO Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Pharmaceutical Development Preclinical CRO Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Pharmaceutical Development Preclinical CRO Raw Material
Table 120. Key Suppliers of Pharmaceutical Development Preclinical CRO Raw Materials
List of Figures
Figure 1. Pharmaceutical Development Preclinical CRO Picture
Figure 2. Global Pharmaceutical Development Preclinical CRO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Type in 2023
Figure 4. Bioanalysis and DMPK Studies
Figure 5. Toxicology Testing
Figure 6. Safety Pharmacology
Figure 7. Others
Figure 8. Global Pharmaceutical Development Preclinical CRO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Application in 2023
Figure 10. Small and Medium Pharmaceutical Company Picture
Figure 11. Large Pharmaceutical Company Picture
Figure 12. Global Pharmaceutical Development Preclinical CRO Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Pharmaceutical Development Preclinical CRO Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Pharmaceutical Development Preclinical CRO Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Region in 2023
Figure 17. North America Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Pharmaceutical Development Preclinical CRO Revenue Share by Players in 2023
Figure 23. Pharmaceutical Development Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Pharmaceutical Development Preclinical CRO Market Share in 2023
Figure 25. Global Top 6 Players Pharmaceutical Development Preclinical CRO Market Share in 2023
Figure 26. Global Pharmaceutical Development Preclinical CRO Consumption Value Share by Type (2019-2024)
Figure 27. Global Pharmaceutical Development Preclinical CRO Market Share Forecast by Type (2025-2030)
Figure 28. Global Pharmaceutical Development Preclinical CRO Consumption Value Share by Application (2019-2024)
Figure 29. Global Pharmaceutical Development Preclinical CRO Market Share Forecast by Application (2025-2030)
Figure 30. North America Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 40. France Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Region (2019-2030)
Figure 47. China Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 50. India Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
Figure 64. Pharmaceutical Development Preclinical CRO Market Drivers
Figure 65. Pharmaceutical Development Preclinical CRO Market Restraints
Figure 66. Pharmaceutical Development Preclinical CRO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Pharmaceutical Development Preclinical CRO in 2023
Figure 69. Manufacturing Process Analysis of Pharmaceutical Development Preclinical CRO
Figure 70. Pharmaceutical Development Preclinical CRO Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Charles River Wuxi AppTec Labcorp Eurofins Scientific PPD, Inc. ICON Plc. Pharmaron Inotiv ChemPartner JOINN Lab EVOTEC Medicilon Crown Bioscience Champion Oncology
Related Reports
30 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
